Fig. 4From: Prognostic implication of serum glycated albumin for patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary interventionSubgroup analysis evaluating the robustness of GA in predicting the risk of the primary endpoint. The analysis was adjusted for Model 5 except for variates applied for grouping. HR was evaluated by per 1-unit increase of GA. BMI body mass index, OHA oral hypoglycemic agentsBack to article page